Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Liver Stiffness to Assess Central Venous Pressure in HF
Author(s): Nicolas Girerd Added: 8 months ago
ESC HF 25 - Outcomes from a study investigating liver stiffness measurement as a non-invasive method to assess central venous pressure showed immediate results at bedside obtained in >4 minutes, with the procedure easily performed by a trained nurse.Prof Nicolas Girerd (University Hospital of Nancy, Nancy, FR) discusses a pilot validation study investigating liver stiffness as a non-invasive… View more

Cardiovascular Renal Metabolic

Heart Failure
Semaglutide Modulates Key Pathways to Resolve MASH, Proteomic Analysis Reveals
Added: 6 months ago Source:  Radcliffe CVRM
A new study has explored the underlying mechanisms by which semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA), improves outcomes in patients with metabolic dysfunction-associated steatohepatitis (MASH).¹ The research, which combined analysis of a phase 2 clinical trial with preclinical models, identified a unique proteomic signature associated with treatment and suggests that… View more

Cardiovascular Renal Metabolic
EASD 23: Efinopegdutide in NAFLD & T2D patients
Author(s): Samuel S Engel Added: 2 years ago
EASD 2023 — In this short interview, Dr Samuel S Engel (Associate Vice President at Merck) discusses a study investigating the effectiveness and safety of efinopegdutide (MK-6024) in patients with nonalcoholic fatty liver disease and type 2 diabetes (NCT04944992).The phase IIa study randomized 145 participants (efinopegdutide, n = 72; semaglutide, n = 73). The majority (55.2%) of participants… View more

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
The 7th Global NAFLD/MASLD Congress
Start date: Jun 24, 2024 End date: Jun 25, 2024
The conference is in production. If you would like to speak at this meeting contactlauren@globalengage.co.uk. NAFLD/MASLD continues to be a huge unmet clinical need globally, and although no therapy has received regulatory approval, there continues to be research advancing ourunderstanding of the disease’s mechanisms. Developments innon-invasivediagnostic biomarkerscontinue to offer the hope… View more

Cardiovascular Renal Metabolic
AHA 25: Pregnancy and CKM Health: Essential Knowledge for Cardiologists
Author(s): Emily Lau Added: 2 months ago
AHA Scientific Sessions 2025 - Dr Emily Lau (Brigham and Women's Hospital, US) joins us to discuss what cardiologists need to know about the intersection of pregnancy and cardiovascular-kidney-metabolic health, from pre-conception counseling through long-term postpartum care.Interview Questions:Why is it important for cardiologists to understand the relationship between pregnancy and… View more

Cardiovascular Renal Metabolic

CV Disease in Special Populations
Bin Li

Author

Tao Zeng

Author

TCT 24: The EVOLVED Trial
Author(s): Marc Dweck Added: 1 year ago
TCT Conference 2024 - Clinical outcomes of early intervention in patients with asymptomatic aortic stenosis (AS) did not impact the composite primary outcome of all cause mortality and unplanned AS related hospitalisation.Dr Marc Dweck (University of Edinburgh, Edinburgh, UK) joins us in this short interview filmed onsite at TCT Conference to discuss the findings from EVOLVED (NCT03094143;… View more

Imaging & Diagnostics

Intervention
Research Area(s) / Expertise:

Cardio-oncology

Heart Failure

 Job title: Assistant Professor
Dr Giselle Melendez is anAssistant Professor atWake Forest University School of Medicine, Winston-Salem, US.Commencing her scientific career at the University of South Carolina School of Medicine, Dr. Melendez focused on molecular mediators of myocardial extracellular matrix remodeling and heart failure. Notably, her research uncovered vital insights into inflammatory cytokines TNF-α, IL-6, and… View more